- Trials with a EudraCT protocol (69)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
69 result(s) found for: Renal Threshold.
Displaying page 1 of 4.
EudraCT Number: 2017-002443-15 | Sponsor Protocol Number: ICAF-BETA | Start Date*: 2017-09-20 | |||||||||||
Sponsor Name:York Teaching Hospitals NHS Foundation Trust | |||||||||||||
Full Title: Improving cardiac function in high-risk surgical patients: exercise testing, biomarkers and beta-blockade | |||||||||||||
Medical condition: Impaired VE/CO2 on cardio pulmonary exercise testing | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010190-20 | Sponsor Protocol Number: 0908010 | Start Date*: 2009-04-22 | |||||||||||
Sponsor Name:CHU Saint-Etienne | |||||||||||||
Full Title: DETECTION OF ACUTE RENAL FAILURE IN CRITICALLY ILL PATIENTS: A prospective evaluation of cystatin C diagnostic performance | |||||||||||||
Medical condition: critically ill patients hospitalised in inetnsive care unit | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006948-65 | Sponsor Protocol Number: Version 4 | Start Date*: 2007-11-29 |
Sponsor Name:University Hospitals of Leicester NHS Trust | ||
Full Title: The effect of acidosis correction and exercise on tissue wasting and immune function in renal patients | ||
Medical condition: Chronic kidney disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-004272-11 | Sponsor Protocol Number: 2B | Start Date*: 2011-11-30 |
Sponsor Name:Erasmus MC | ||
Full Title: The BOKITO-2B Study: Tenofovir DF Bone and Kidney Toxicity. Incidence and reversibility in HBV-monoinfected patients. | ||
Medical condition: Chronic hepatitis B | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005468-10 | Sponsor Protocol Number: C16011 | Start Date*: 2012-11-28 |
Sponsor Name:Millennium Pharmaceuticals, Inc. | ||
Full Title: A Phase 3 Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment Administered to Patients With Relapsed or Refra... | ||
Medical condition: Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) NL (Completed) GB (Prematurely Ended) IT (Ongoing) GR (Completed) ES (Prematurely Ended) DK (Completed) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-016653-17 | Sponsor Protocol Number: FARM73452X | Start Date*: 2010-04-13 | ||||||||||||||||||||||||||
Sponsor Name:AZIENDA UNITA` SANITARIA LOCALE N 12 DI VIAREGGIO | ||||||||||||||||||||||||||||
Full Title: TREATMENT OF HYPOTENSION IN EXTREMELY PRETERM INFANTS: A MULTICENTER RANDOMIZED CONTROLLED TRIAL | ||||||||||||||||||||||||||||
Medical condition: HYPOTENSION IN EXTREMELY PRETERM INFANTS | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003472-19 | Sponsor Protocol Number: version 4.0, 31 May 2007 | Start Date*: 2007-09-13 |
Sponsor Name:Royal Free Hampstead NHS Trust | ||
Full Title: Determining a viral load threshold for pre-emptive therapy for cytomegalovirus infection in transplant patients using real time PCR monitoring. | ||
Medical condition: Transplant recipients with CMV infection. | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000201-23 | Sponsor Protocol Number: reflect01 | Start Date*: 2013-08-30 |
Sponsor Name:St. Antonius Ziekenhuis | ||
Full Title: A randomised clinical trial evaluating the effect of remifentanil vs fentanyl during cardiac surgery on the incidence of chronic thoracic pain. | ||
Medical condition: chronic thoracic pain after cardiac surgery via sternotomy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005793-63 | Sponsor Protocol Number: CLIK066A2202 | Start Date*: 2013-10-30 |
Sponsor Name:Novartis Pharma Services AG | ||
Full Title: A multi-center, randomized, double-blind, double-dummy, parallel-group dose-finding study to evaluate the change in HbA1c after 12 weeks monotherapy with seven doses of LIK066 compared with placebo... | ||
Medical condition: Type II Diabetes mellitus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Prematurely Ended) SK (Prematurely Ended) IT (Prematurely Ended) PL (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2011-004201-25 | Sponsor Protocol Number: 1B | Start Date*: 2011-11-30 |
Sponsor Name:Erasmus MC | ||
Full Title: The BOKITO-1B Study: Tenofovir DF Bone and Kidney Toxicity. Pharmacology in HBV monoinfected patients. | ||
Medical condition: Chronic hepatitis B | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-001377-31 | Sponsor Protocol Number: HZNP-DAX-203 | Start Date*: 2022-12-09 | |||||||||||
Sponsor Name:Horizon Therapeutics Ireland DAC | |||||||||||||
Full Title: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY EVALUATING THE EFFICACY AND SAFETY OF DAXDILIMAB IN ADULT PARTICIPANTS WITH ACTIVE PROLIFERATIVE LUPUS NEPHRITIS | |||||||||||||
Medical condition: ACTIVE PROLIFERATIVE LUPUS NEPHRITIS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) HR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003867-79 | Sponsor Protocol Number: IDTX-MA-3004 | Start Date*: 2018-11-07 | |||||||||||
Sponsor Name:Astellas Pharma Global Development, Inc. | |||||||||||||
Full Title: Astagraf XL® to Understand the Impact of Immunosuppression on De Novo DSA Development and Chronic Immune Activation in Kidney Transplantation | |||||||||||||
Medical condition: Understand the Impact of Immunosuppression on De Novo DSA Development and Chronic Immune Activation in Kidney Transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002957-42 | Sponsor Protocol Number: EMR200592-001 | Start Date*: 2013-08-06 | |||||||||||
Sponsor Name:Merck KGaA | |||||||||||||
Full Title: A Randomized, Double-Blind, Phase III Study of the Efficacy and Safety of Gemcitabine in Combination With TH-302 Compared With Gemcitabine in Combination With Placebo in Previously Untreated Subjec... | |||||||||||||
Medical condition: Locally advanced unresectable pancreatic adenocarcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) CZ (Prematurely Ended) DE (Completed) HU (Completed) ES (Completed) SK (Completed) IT (Completed) PL (Completed) FI (Completed) NL (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002843-81 | Sponsor Protocol Number: 057 | Start Date*: 2020-01-07 |
Sponsor Name:IMEA | ||
Full Title: Switch to Tenofovir Alafenamide (TAF), Emtricitabine (FTC), Bictegravir (BIC)(Biktarvy®) in HIV-1-infected patients over 65 years old at risk of polymedication | ||
Medical condition: HIV-1-infected patient Age > 65 years old Plasma HIV RNA ≤ 50 copies/mL for ≥ 6 months: one blip between 50 et 200 cp/ml is allowed in the last 6 months before screening. Currently receiving an ant... | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002151-10 | Sponsor Protocol Number: NEUROPROTECTpost-CA | Start Date*: 2015-08-07 | |||||||||||
Sponsor Name:UZ Leuven | |||||||||||||
Full Title: Neuroprotective goal directed hemodynamic optimization in post-cardiac arrest patients: a randomized controlled trial (the NEUROPROTECT post-CA trial) | |||||||||||||
Medical condition: post-cardiac arrest patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001457-43 | Sponsor Protocol Number: APHP200388 | Start Date*: 2020-04-10 |
Sponsor Name:APHP | ||
Full Title: Dexamethasone and oxygen support strategies in ICU patients with Covid-19 pneumonia | ||
Medical condition: acute hypoxemic respiratory failure (AHRF) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-005830-14 | Sponsor Protocol Number: CVAY736K12301 | Start Date*: 2022-06-13 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A randomized, double-blind, parallel group, placebo-controlled, multicenter phase 3 trial to evaluate the efficacy, safety and tolerability of ianalumab on top of standard-of-care therapy in partic... | |||||||||||||
Medical condition: Lupus nephritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) HU (Ongoing) IT (Ongoing) ES (Ongoing) CZ (Ongoing) EE (Ongoing) LT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002927-40 | Sponsor Protocol Number: ANAM-17-21 | Start Date*: 2019-06-19 |
Sponsor Name:Helsinn Healthcare SA | ||
Full Title: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia i... | ||
Medical condition: Treatment of malignancy associated weight loss or anorexia in patients with NSCLC | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) BE (Completed) PL (Completed) HR (Completed) RO (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2015-001442-29 | Sponsor Protocol Number: D3461C00007 | Start Date*: 2016-01-14 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 2 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Proliferative Lupus Nephritis | |||||||||||||
Medical condition: Lupus Nephritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) HU (Completed) DE (Completed) ES (Completed) GB (GB - no longer in EU/EEA) FR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004698-29 | Sponsor Protocol Number: TH-CR-415 | Start Date*: 2014-05-12 | ||||||||||||||||
Sponsor Name:Threshold Pharmaceuticals, Inc. | ||||||||||||||||||
Full Title: A Randomized Phase 2, Double-blind, Placebo-controlled, Multi-center Study Comparing Pemetrexed in Combination with TH-302 vs. Pemetrexed in Combination with Placebo as Second-line Chemotherapy for... | ||||||||||||||||||
Medical condition: Advanced Non-Squamous, Non-Small Cell Lung Cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Prematurely Ended) IT (Completed) DE (Prematurely Ended) CZ (Completed) GR (Prematurely Ended) ES (Temporarily Halted) RO (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.